Kristiansen, Glen <br/><br/>
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.  [electronic resource] 

 -  The American journal of pathology  Oct 2002 
 - 1215-21 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/S0002-9440(10)64398-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--mortality<br/>Antigens, CD--analysis<br/>Biomarkers, Tumor--analysis<br/>CD24 Antigen<br/>Cell Nucleus--pathology<br/>Cystadenoma--pathology<br/>Cytoplasm--pathology<br/>Endometrial Neoplasms--pathology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Membrane Glycoproteins<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Ovarian Neoplasms--mortality<br/>Ovary--cytology<br/>Predictive Value of Tests<br/>Prognosis<br/>Reference Values<br/>Retrospective Studies<br/>Survival Rate<br/>Time Factors